Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being

Completed · Phase 1

Conditions studied: Fetal Testing, Transplacental Transfer of Acetaminophen

In brief

This study has two aims: 1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients) 2. to understand the impact of maternal acetaminophen use on fetal movement and breathing (20 patients)

Key facts

Study ID

NCT01211912

Run by

Mayo Clinic

People needed

56

Starts

2010-09-01

Expected to finish

2011-12-01

Last updated by the study team

2014-09-01

Who can join

Age: 18 and older, up to 44. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant females
• Age 18-44
• Any race
• Any parity
• Singleton Gestations
• Weight between 60-90 kg

You may not qualify if…

• Acetaminophen Allergy
• Contraindication to Acetaminophen Use
• Chorioamnionitis
• Preeclampsia
• Diabetes Mellitus
• Placental Abruption
• Placenta Previa
• Fetal Anomaly
• Intrauterine growth restriction (IUGR)
• Multiple Gestations
• Maternal Medical Disease
• Acetaminophen use in the last 3 days
• Plan to donate or bank fetal cord blood

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.